DK2240462T3 - 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst - Google Patents

3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst

Info

Publication number
DK2240462T3
DK2240462T3 DK09702525.8T DK09702525T DK2240462T3 DK 2240462 T3 DK2240462 T3 DK 2240462T3 DK 09702525 T DK09702525 T DK 09702525T DK 2240462 T3 DK2240462 T3 DK 2240462T3
Authority
DK
Denmark
Prior art keywords
glaucome
dihydroxycyclopentane
derivatives
treatment
hair growth
Prior art date
Application number
DK09702525.8T
Other languages
English (en)
Inventor
Brent A Johnson
David W Old
Yariv Donde
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2240462T3 publication Critical patent/DK2240462T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09702525.8T 2008-01-18 2009-01-14 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst DK2240462T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2228208P 2008-01-18 2008-01-18
US12/352,995 US7964595B2 (en) 2008-01-18 2009-01-13 Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
PCT/US2009/030895 WO2009091765A1 (en) 2008-01-18 2009-01-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
DK2240462T3 true DK2240462T3 (da) 2013-10-28

Family

ID=40876973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09702525.8T DK2240462T3 (da) 2008-01-18 2009-01-14 3,5-dihydroxycyclopentanderivater til anvendelse i behandling af glaukom eller okulær hypertension og til stimulering af hårvækst

Country Status (9)

Country Link
US (1) US7964595B2 (da)
EP (1) EP2240462B1 (da)
JP (1) JP5393700B2 (da)
AU (1) AU2009205478B2 (da)
BR (1) BRPI0906879A2 (da)
CA (1) CA2712192C (da)
DK (1) DK2240462T3 (da)
ES (1) ES2434963T3 (da)
WO (1) WO2009091765A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011002383A (es) 2008-09-04 2011-04-07 Santen Pharma Co Ltd Agente para promover el crecimiento del pelo que contiene un derivado de 15,15-difluoroprostaglandina f2a como ingrediente activo.
EP2857002A4 (en) * 2012-05-30 2015-12-09 Asahi Glass Co Ltd COMPOSITION FOR CAPILLARY GROWTH
US9540357B1 (en) 2014-07-31 2017-01-10 Allergan, Inc. 15-aryl prostaglandins as EP4 agonists, and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
JPH0692305B2 (ja) * 1987-05-15 1994-11-16 株式会社上野製薬応用研究所 体温上昇剤
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
AU3861700A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Aldehyde intermediates for the preparation of prostaglandin derivatives
ES2232434T3 (es) * 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US7166730B2 (en) * 2000-01-27 2007-01-23 Fine Tech Laboratories, Ltd Process for the preparation of prostaglandin derivatives
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Also Published As

Publication number Publication date
BRPI0906879A2 (pt) 2015-07-07
ES2434963T3 (es) 2013-12-18
AU2009205478B2 (en) 2014-01-16
WO2009091765A1 (en) 2009-07-23
CA2712192A1 (en) 2009-07-23
AU2009205478A1 (en) 2009-07-23
US7964595B2 (en) 2011-06-21
EP2240462A1 (en) 2010-10-20
US20090186885A1 (en) 2009-07-23
EP2240462B1 (en) 2013-08-21
JP2011522775A (ja) 2011-08-04
JP5393700B2 (ja) 2014-01-22
CA2712192C (en) 2016-06-14

Similar Documents

Publication Publication Date Title
CY2018026I1 (el) Χρηση στρωματικων βλαστοκυτταρων λαμβανομενων απο λιπωδη ιστο στην θεραπεια συριγγιου
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK1799235T3 (da) Sammensætninger af fosterhudcelleprotein til behandling af hudtilstande, -lidelser eller -sygdomme og fremgangsmåder til fremstilling og anvendelse deraf
DK2245199T3 (da) Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
DK2306977T3 (da) Fremgangsmåde og sammensætning til behandling af okulær hypertension og glaukom
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
DK1993575T3 (da) Sammensætninger omfattende humane embryostamceller og derivater deraf, fremgangsmåder til anvendelse og fremgangsmåder til fremstilling
BRPI0821658A2 (pt) Anticorpos contra nkg2d humano e usos dos mesmos
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
BRPI0816214A2 (pt) Uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
BRPI0915986A2 (pt) composição, métodos para tratar uma condição, para retardar o início de uma condição, para reduzir o risco em um indivíduo de adquirir uma condição e para alterar a expressão de um ou mais genes em um indivíduo
BRPI0810270A2 (pt) "implante de válvula cardíaca e método de implante"
DK2297106T3 (da) Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
PT2254869T (pt) Novos derivados de 1-benzil-3-hidroximetilindazole e suas utilizações no tratamento de doenças com base na expressão de cx3cr1 e p40
IL202293A0 (en) 1,(,3)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
DK2158201T3 (da) Derivater af 7-alkynyl-1,8-naphthyridon, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapi
BRPI0909447A2 (pt) Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
DK2262778T5 (da) 1-benzyl-3-hydroxymethylindazolderivativer og brug deraf i behandling af sygdomme baseret på ekspression af mcp-1, cx3cr1 og p40
BR112012001344A2 (pt) derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
BRPI0822843A2 (pt) "dispositivo portátil para tratamento de cabelo para estimulação de crescimento do cabelo no couro cabeludo"
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DK2407474T3 (da) Triacetyl-3-hydroxyfenyladenosin og dets anvendelse til regulering af blodfedt